**Author details**

Xi-Dai Long1,2\*† , Wei-Zhong Tang3† , Jun Lu2† , Xiao-Ying Huang1† , Jin-Guang Yao1,4† , Tian-Qi Zhang1† , Xing-Zhizi Wang1† , Qun-Ying Su1† , Chun-Ying Luo<sup>1</sup> , Xue-Ming Wu<sup>1</sup> , Chao Wang<sup>5</sup> , Li-Xia Zeng<sup>6</sup> , Qiang Xia<sup>2</sup> and Yun Ma<sup>6</sup>

[7] Nault JC. Pathogenesis of hepatocellular carcinoma according to aetiology. Best Practice & Research. Clinical Gastroenterology. 2014;**28**:937-947. DOI: 10.1016/j.bpg.2014.08.006 [8] Tsuchiya N, Sawada Y, Endo I, Saito K, Uemura Y, Nakatsura T. Biomarkers for the early diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology. 2015;**21**:

The Diagnostic and Prognostic Potential of MicroRNAs for Hepatocellular Carcinoma

http://dx.doi.org/10.5772/intechopen.72276

119

[9] Hung CH, TH H, SN L, Kuo FY, Chen CH, Wang JH, Huang CM, Lee CM, Lin CY, Yen YH, Chiu YC. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus. International Journal of Cancer.

[10] Huang JT, Liu SM, Ma H, Yang Y, Zhang X, Sun H, Zhang X, Xu J, Wang J. Systematic review and meta-analysis: Circulating miRNAs for diagnosis of Hepatocellular carci-

[11] Zhang YC, Xu Z, Zhang TF, Wang YL. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma. World Journal of Gastroenterology. 2015;

[12] Chang-Hao Tsao S, Behren A, Cebon J, Christophi C. The role of circulating microRNA in hepatocellular carcinoma. Frontiers in Bioscience (Landmark Ed). 2015;**20**:78-104 [13] Yang Y, Zhu R. Diagnostic value of circulating microRNAs for hepatocellular carcinoma. Molecular Biology Reports. 2014;**41**:6919-6929. DOI: 10.1007/s11033-014-3578-7

[14] KZ Q, Zhang K, Li H, Afdhal NH, Albitar M. Circulating microRNAs as biomarkers for hepatocellular carcinoma. Journal of Clinical Gastroenterology. 2011;**45**:355-360. DOI:

[15] Wong KF, Xu Z, Chen J, Lee NP, Luk JM. Circulating markers for prognosis of hepatocellular carcinoma. Expert Opinion on Medical Diagnostics. 2013;**7**:319-329. DOI:

[16] Zhao X, Yang Z, Li G, Li D, Zhao Y, Wu Y, Robson SC, He L, Xu Y, Miao R, Zhao H. The role and clinical implications of microRNAs in hepatocellular carcinoma. Science China.

[17] Lyra-Gonzalez I, Flores-Fong LE, Gonzalez-Garcia I, Medina-Preciado D, Armendariz-Borunda J. MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine. World Journal of Hepatology. 2015;**7**:1530-1540. DOI: 10.4254/wjh.v7.i11.1530

[18] Cardin R, Piciocchi M, Bortolami M, Kotsafti A, Barzon L, Lavezzo E, Sinigaglia A, Rodriguez-Castro KI, Rugge M, Farinati F. Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: An intricate pathway. World Journal

[19] Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of

[20] Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proceedings of the National Academy of Sciences of the United States of

of Gastroenterology. 2014;**20**:3078-3086. DOI: 10.3748/wjg.v20.i12.3078

America. 2007;**104**:3300-3305. DOI: 10.1073/pnas.0611347104

tissue-specific microRNAs from mouse. Current Biology. 2002;**12**:735-739

Life Sciences. 2012;**55**:906-919. DOI: 10.1007/s11427-012-4384-x

noma. Journal of Cellular Physiology. 2016;**231**:328-335. DOI: 10.1002/jcp.25135

10573-10583. DOI: 10.3748/wjg.v21.i37.10573

2016;**138**:714-720. DOI: 10.1002/ijc.29802

**21**:9853-9862. DOI: 10.3748/wjg.v21.i34.9853

10.1097/MCG.0b013e3181f18ac2

10.1517/17530059.2013.795146

\*Address all correspondence to: sjtulongxd@263.net or yunandama@hotmail.com

1 Department of Pathology, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, PR China

2 Department of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, PR China

3 Department of Gastrointestinal Surgery, the Affiliated Tumor Hospital, Guangxi Medical University, Nanning, PR China

4 Department of Medicine, Guangxi Scientific Technological University School of Medicine, Liuzhou, PR China

5 Department of Medicine, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, PR China

6 Department of Pathology, the Affiliated Tumor Hospital, Guangxi Medical University, Nanning, PR China

† These authors contributed equally
